Clinical Trial Update: ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

View source ↗

Summary

The ELEVATE registry, sponsored by Alnylam Pharmaceuticals, targets patients with Acute hepatic porphyria and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Porphyria

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Acute Hepatic Porphyria | Status: RECRUITING